These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 3367303)
1. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate. Cherian MG; Miles EF; Clarkson TW; Cox C J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303 [TBL] [Abstract][Full Text] [Related]
2. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury. Zalups RK J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154 [TBL] [Abstract][Full Text] [Related]
3. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Aposhian MM; Dart RC; Woods JS; Ostrosky-Wegman P; Gonsebatt ME; Aposhian HV J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576 [TBL] [Abstract][Full Text] [Related]
4. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney. Diamond GL; Klotzbach JM; Stewart JR J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658 [TBL] [Abstract][Full Text] [Related]
5. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315 [TBL] [Abstract][Full Text] [Related]
6. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. Gonzalez-Ramirez D; Maiorino RM; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Aposhian MM; Dart RC; Diaz Gama JH; Echeverria D J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats. Juresa D; Blanusa M; Kostial K Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364 [TBL] [Abstract][Full Text] [Related]
9. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden. Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843 [TBL] [Abstract][Full Text] [Related]
10. Chelation in metal intoxication. XX: Effect of pre-treatment with chelators on the distribution of mercury. Kachru DN; Tandon SK Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):399-402. PubMed ID: 3016847 [TBL] [Abstract][Full Text] [Related]
11. DMPS as a rescue agent for the nephropathy induced by mercuric chloride. Zalups RK; Gelein RM; Cernichiari E J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092 [TBL] [Abstract][Full Text] [Related]
12. The effect of 2,3-dimercaptopropane sodium sulfonate on mercury retention in rats in relation to age. Kostial K; Kargacin B; Blanusa M; Landeka M Arch Toxicol; 1984 Oct; 55(4):250-2. PubMed ID: 6517703 [TBL] [Abstract][Full Text] [Related]
13. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use. Twarog T; Cherian MG Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504 [TBL] [Abstract][Full Text] [Related]
14. Note on the metabolism of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate. Gabard B; Walser R J Toxicol Environ Health; 1979 Jul; 5(4):759-64. PubMed ID: 490684 [TBL] [Abstract][Full Text] [Related]
15. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney. Klotzbach JM; Diamond GL Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889 [TBL] [Abstract][Full Text] [Related]
16. Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors. Buchet JP; Lauwerys RR Toxicology; 1989 Mar; 54(3):323-33. PubMed ID: 2539660 [TBL] [Abstract][Full Text] [Related]
17. 2,3-Dimercaptopropane-1-sodium sulfonate for reducing retention of ingested 203Hg in suckling rats. Kostial K; Kargacin B; Landeka M Bull Environ Contam Toxicol; 1988 Aug; 41(2):185-8. PubMed ID: 3207899 [No Abstract] [Full Text] [Related]
18. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children. Chisolm JJ; Thomas DJ J Pharmacol Exp Ther; 1985 Dec; 235(3):665-9. PubMed ID: 4078728 [TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806 [TBL] [Abstract][Full Text] [Related]
20. Effect of mercuric chloride on urinary excretion of free hydroxyproline. Siddiqi NJ; Alhomida AS Med Sci Monit; 2006 Mar; 12(3):BR95-101. PubMed ID: 16501418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]